Lenny Dang

Table 1, Extended probe submitted to the MLSMR

Douglas S. Auld, Henrike Veith, Hee-Won Park, 2013 .

Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations

Tak W. Mak, Lenny Dang, Masato Sasaki, 2010, The Journal of experimental medicine.

Targeted Inhibition of Mutant IDH2 in Leukemia Cells Induces Cellular Differentiation

Fang Wang, Erica Hansen, Francesco G. Salituro, 2013, Science.

AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic IDH2 Mutations.

Hua Yang, Fang Wang, Zenon Konteatis, 2017, Cancer discovery.

MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-{kappa}B-dependent lymphoma.

Mark Manfredi, Lenny Dang, Usha Narayanan, 2010, Blood.

MLN120B, a Novel IκB Kinase β Inhibitor, Blocks Multiple Myeloma Cell Growth In vitro and In vivo

Hiroshi Yasui, Kenneth C. Anderson, Paul G. Richardson, 2006, Clinical Cancer Research.